Not provided
Not provided
Not provided
Not provided
Not provided
Study did not receive funding and was administratively withdrawn.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The investigators goal is to pilot a substance use-related brief intervention (BI) for youth with chronic medical conditions, obtaining preliminary evidence of feasibility, acceptability and impacts of the approach for reducing substance use among this group.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Treatment as Usual | No Intervention | Those in the Treatment as Usual group will not receive the brief intervention for substance use but will receive a brief health education brochure. | |
| Brief Intervention | Experimental | Those in the Brief Intervention group will receive a brief motivational intervention aimed at encouraging the participant to decrease their substance use. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Brief Intervention | Behavioral | Those in the intervention arm will undergo a 10-minute discussion with a trained interventionist aimed at encouraging decreased substance use. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Percent days abstinent | We will compare the percent days abstinent from substances between the Treatment as Usual and Intervention groups 30 days post baseline | 30 days post baseline |
| Measure | Description | Time Frame |
|---|---|---|
| Medical complications | We will evaluate the incidents of disease complications between the Treatment as Usual and Intervention groups 30 days post baseline | 30 days post baseline |
| Measure | Description | Time Frame |
|---|---|---|
| Percent Days Abstinent 90 days post baseline | We will compare the percent days abstinent from substances between the Treatment as Usual and Intervention groups 90 days post baseline | 90 days post baseline |
| Medical complications 90 days post baseline |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sharon Levy, MD, MPH | Boston Children's Hospital | Principal Investigator |
| Elissa Weitzman, ScD, MSc | Boston Children's Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Boston Children's Hospital | Boston | Massachusetts | 02115 | United States |
Not provided
| ID | Term |
|---|---|
| D000437 | Alcoholism |
| D019966 | Substance-Related Disorders |
| D003920 | Diabetes Mellitus |
| D001171 | Arthritis, Juvenile |
| D003093 | Colitis, Ulcerative |
| ID | Term |
|---|---|
| D019973 | Alcohol-Related Disorders |
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
| D044882 | Glucose Metabolism Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D003419 | Crisis Intervention |
| ID | Term |
|---|---|
| D011613 | Psychotherapy |
| D004191 | Behavioral Disciplines and Activities |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
We will evaluate the incidents of disease complications between the Treatment as Usual and Intervention groups 30 days post baseline
| 90 days post baseline |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
| D003240 | Connective Tissue Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
| D003092 | Colitis |
| D005759 | Gastroenteritis |
| D005767 | Gastrointestinal Diseases |
| D004066 | Digestive System Diseases |
| D015212 | Inflammatory Bowel Diseases |
| D003108 | Colonic Diseases |
| D007410 | Intestinal Diseases |